about
Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains.CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1+ NK cells.Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infectionsCharacterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus
P50
Q38714918-FACD4776-2ED2-4E80-ABB5-9F10961C205DQ38741001-05AB7493-562B-4757-82AF-8F24032E99AEQ40467077-FDF48EDB-0D3B-4176-BD86-46E0695DE8D9Q42220642-46D321FD-9114-42E1-A669-5C188A585FD8Q42726182-323F4DC0-B83F-4B5A-BBF8-462EF4CD47DEQ91016077-2315E74D-4806-434B-B693-5016A9760FB6Q93028510-60FC172B-04D4-470C-8F02-BE4D95771415
P50
description
investigador
@es
researcher
@en
name
Nandini Makwana
@en
type
label
Nandini Makwana
@en
prefLabel
Nandini Makwana
@en
P108
P31
P496
0000-0002-4534-2771